Here are relevant reports on : ai-in-veterinary-diagnostics-market
-
Noninvasive Cancer Diagnostics Market by Instruments (Solid Tumor, Blood Cancer, Lung Cancer, Breast Cancer), Technology (Clinical Chemistry, Immunochemistry, Molecular Diagnostics) - Analysis & Global Forecast to 2019
The global non-invasive cancer diagnostic market is expected to show considerable growth during the forecast period. This is attributed to growing cancer cases worldwide, especially breast and lung cancer. In 2013, in the U.S. there were more than 1,660,290 new cases of all type of cancers diagnosed in 2013 (American Cancer Society). Increased healthcare expenditure and increase research and development activities are some of the other factors driving the growth of this market. However factors such as high cost of treatment, and stringent regulatory guidelines are limiting the market growth.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Europe Companion Animal Diagnostics Market by Product (Consumables, Instruments), Technology (Clinical Biochemistry, Molecular Diagnostics), Application (Clinical Pathology, Virology, Hematology), Animal (Dogs, Cats), End User - Forecast to 2031
The Europe companion animal diagnostics market, valued at USD0.43 billion in 2025, stood at USD0.46 billion in 2026 and is projected to advance at a resilient CAGR of 8.6% from 2026 to 2031, culminating in a forecasted valuation of USD0.70 billion by the end of the period. The market for diagnostics of companion animals in Europe is experiencing fast growth owing to factors such as increased pet ownership, animal health awareness, and advanced veterinary care being more widely accepted and costly.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Precision Diagnostics & Medicine Market by Diagnostic Testing (Genetic, DTC), Diagnostics Indication (Oncology, Neurology, Immunology), Therapeutic Products (Inhibitors, mAbs, CGT), Indication (Oncology, Rare Disease, Infectious) - Global Forecast to 2029
The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, stood at US$145.53 billion in 2024 and is projected to advance at a resilient CAGR of 11.1% from 2024 to 2029, culminating in a forecasted valuation of US$246.66 billion by the end of the period. Factors such as the growing integration of AI and ML to enhance precision diagnostics and medicine development supported by rising collaborations between pharmaceutical and diagnostics companies to improve precision healthcare and the rise in direct-to-consumer testing are driving the growth in the market.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Exosome Diagnostics and Therapeutics Market by Type (Diagnostics, Therapeutics), Product & Service (Instruments, Kits, Reagents), Source (Stem Cells, Blood, Blood Plasma, Urine), Application (Cancer, Musculoskeletal, CVD) - Global Forecast to 2032
The global exosome diagnostics and therapeutics market, valued at US$33 million in 2023, stood at US$59 million in 2024 and is projected to advance at a resilient CAGR of 81.2% from 2024 to 2032, culminating in a forecasted valuation of US$6,848 million by the end of the period. The growth of this market is driven by factors such as the increasing collaborations & commercialization initiatives, emerging potential of exosome-based liquid biopsy, and growing outsourcing of exosome manufacturing activities.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Malaria Diagnostics Market by Technology (Microscopy, Rapid Diagnostic Tests, Molecular Diagnostic Tests), End User (Hospitals, Clinics, Diagnostics Centers, and Others), and Geography - Global Forecast to 2027
The global malaria diagnostics market size is projected to reach USD 1.02 Billion by 2027 from USD 770.5 million in 2022, at a CAGR of 5.4% during the forecast period. Market is driven by factors such as rise in the prevalence of malaria in developing countries. Moreover, the surge in awareness initiatives by governments and the increase in research for new malaria diagnostics are the factors that boost the growth of this market. However, lack of alertness about healthcare in developing countries is a major factor that restricts the malaria diagnostics market growth.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Stroke AI Market by Offering (Software, [AI], Services), Classification (ICD, CPT, HCPCS), Specialty (Surgical, Radiology), Function (Code, Assignment, Reimbursement, Analytics, Denial, Audit), End User (Hospital, ASC, Payers) - Global Forecast to 2030
The global stroke AI market, valued at US$0.22 billion in 2024, stood at US$0.32 billion in 2025 and is projected to advance at a resilient CAGR of 38.4% from 2025 to 2030, culminating in a forecasted valuation of US$1.60 billion by the end of the period. The stroke AI market is growing steadily, driven by the need for faster stroke detection, improved clinical decision-making, and reduced time-to-treatment. Increasing adoption of AI-enabled CT and MRI analysis for stroke triage, coupled with rising stroke incidence, aging populations, and hospital digitization, is accelerating demand.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Artificial Intelligence (AI) Market by Infrastructure (Compute, Memory, Networking, Storage), Software (Conversational Assistants, No Code/Low Code, BI & Analytics, Developer Platforms), Technology (ML, NLP, Generative AI) - Forecast to 2032
The Asia Pacific artificial intelligence (AI) market size is projected to reach 815.98 billion by 2032. The Key Players include Baidu (China), Alibaba Cloud (China), Huawei (China), Microsoft (US), AMD (US), Qualcomm (US), NVIDIA (US), Intel (US), Google (US), Appier (Taiwan), SenseTime (China), Oracle (US), IBM (US), along with startups/SMEs such as Advance.ai (Singapore) and Cinnamon AI (Japan).
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Emotion AI Market by Solutions (Emotion Recognition, Emotion AI SDKs and APIs, Emotion Analytics), Type (Text-Focused, Voice-Focused, Video & Multimodal), Technology (Machine Learning, NLP, Computer Vision) - Global Forecast to 2030
The Emotion AI market is projected to reach USD 9.01 billion by 2030, at a CAGR of 21.9% during the forecast period. The report profiles key players such as IBM (US), Microsoft (US), Google (US), Amazon (US), Smart Eye (Sweden), Entropik Tech (India), Uniphore (US), Audeering GmbH (Germany), VIER GmbH (Germany), Cognitec (Germany), Symanto (Germany), Realeyes (UK), CIPIA Vision (Israel), Noldus (Netherlands), Cogito (US), Morphcast (US), Voicesense (Israel), Superceed (Malaysia), Siena AI (US), Opsis (Singapore), Behavioral Signals (US), Hume (US), Kairos (US), Beemotion.AI (Australia), Intelligent Voice (UK), Davi (France), Utrigg (Ukraine), AttentionKart (India) and VERN AI (US).
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
AI Application-Specific Integrated Circuit (ASIC) Market Size, Share & Trends by Inference ASICs, Training ASICs, Edge AI Accelerators, and Cloud Data Center Chips - Global Forecast to 2032
The global AI Application-Specific Integrated Circuit (ASIC) market size was valued at USD 12.45 billion in 2025 and is projected to reach USD 35.80 billion by 2032, expanding at a robust CAGR of 16.3% from 2026 to 2032. This exponential trajectory is primarily driven by the transition from model training to large-scale, high-volume inference applications across hyperscale data centers. As generative AI transitions from research environments to mass commercial deployment, enterprises are demanding purpose-built custom AI chips capable of maximizing throughput and minimizing the cost per token.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Causal AI Market by Offering (Causal AI Platforms, Causal Discovery, Causal Inference, Causal Modelling, Root Cause Analysis), Application (Financial Management, Sales & Customer Management, Operations & Supply Chain Management) - Global Forecast to 2030
The causal AI market is projected to reach USD 456.8 million by 2030, expanding at a CAGR of 41.8% during the forecast period. The major players in the Causal AI market include IBM (US), Logility (US), CausaLens (UK), Aitia (US), Causely (US), Geminos (US), along with SMEs and startups such as Data Poem (US), CausaAI (Netherlands), Causa (UK), Lifesight (US), amd Actable AI (UK).
- Published: December 2024
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
